Relatively limited data exist on the natural history of untreated Peyronie's Disease (PD). Here, we sought to evaluate and report on the natural history of patient-reported changes in penile curvature, pain, and shortening in men with untreated PD.
INTRODUCTION AND OBJECTIVES:
Relatively limited data exist on the natural history of untreated Peyronie's Disease (PD). Here, we sought to evaluate and report on the natural history of patient-reported changes in penile curvature, pain, and shortening in men with untreated PD.
METHODS: We identified all patients who underwent evaluation for PD at our institution between 1990 and 2012. 719 patients were randomly selected to receive a mail-in questionnaire with questions relating to the natural history of PD, including topics of change in curvature, pain, and shortening over time. Results were subsequently summarized as a descriptive report, and statistical comparisons were performed where appropriate.
RESULTS: A total of 162 patients (23% response rate) completed the mail-in survey. Of these, 125 had no history of prior intralesional or surgical therapy for PD, and these patients comprised our study cohort. Median (IQR) patient age at diagnosis was 65 (62;68), and PD duration was 8.4 (5;12) years. Eighty-six percent of patients presented with penile curvature including 46% dorsal/ventral and 54% lateral, per patient report. Twelve percent of patients reported multiplanar curvature and 84% estimated their curvature as < 45 degrees. Penile curvature resolved in 16%, improved in 27%, worsened in 20%, and remained stable in 37% of patients. Interestingly, 12% of patients developed a new penile curvature at a median (IQR) of 17 (11;39) months after initial presentation, and these patients were significantly more likely to report worsening of their initial penile curvature (p¼0.01). Fifty-four percent of patients reported penile indentation or narrowing. Penile pain was reported in 60% of patients, of whom the pain improved (18%) or resolved (64%) at a median (IQR) of 12 (6;24) months. Sixtyfive percent of patients reported penile shortening, with 30% noting progressive shortening over time.
CONCLUSIONS: The current report provides additional understanding on the natural history of untreated PD. Contrary to some reports, the majority of men note curvature stability or improvement, resolution of pain, and progressive penile shortening over time. Only 20% reported worsening of curvature after disease stability, with 12% developing de novo curvature. This information significantly enhances our understanding and provides data for counseling patients with newly diagnosed PD. METHODS: A retrospective analysis of 212 men with PD presenting to a single academic andrology clinic was performed. Age, date of disease onset, body mass index (BMI), smoking history, erectile dysfunction (ED), hyperlipidemia (HLD), diabetes mellitus (DM), hypertension (HTN) and past and current medications were evaluated. All cases were confirmed with penile ultrasound to quantify plaque size, as well as degree and direction of penile curvature. Linear and logistic regression analysis was used to examine relationships between variables.
RESULTS: Men with PD and ED (ED+PD group) and those with PD alone (PD group) were examined for variables that impact PD development and progression. Of the 212 men with PD, 149 (70.3%) self-reported ED. Furthermore, smoking and HLD were significantly associated with the development of ED in men with PD. Nineteen men were current and 41 were former smokers. The prevalence of ED was 64% in men without HLD but 79% in men with HLD (p¼0.018). Logistic regression demonstrated that both HLD and smoking history increased the risk of ED (OR 2.3 and 2.2, 95% CI 1.16-4.47 and 1.14-7.59, respectively). Penile curvature and plaque characteristics did not correlate with the presence of ED, suggesting a vascular etiology for the ED in men in our cohort, rather than one related to fibrosis. In nonsmokers, the presence of HLD was associated with a plaque volume that was 151.27 mm 3 greater than in men without HLD, adjusting for age, BMI, and duration of PD (p¼0.018). History of trauma, age of onset, duration of symptoms and overall plaque volume were not correlated with angle of curvature. When assessing angle of curvature, a 1 cm increase in plaque length correlated with an 8.8 degree increase in curvature.
CONCLUSIONS: Hyperlipidemia contributes to increased PD plaque volume and risk of ED, independent of penile curvature or plaque characteristics, suggesting a vascular etiology for ED in some men with PD. These data provide a basis for cardiovascular risk factor modification in affected men. Furthermore, longer penile plaques correlate with more significant penile curvature. These results further facilitate risk stratification and counseling of men with PD. Patients were identified using ICD-9-CM diagnosis codes for PD (60785). Surgical intervention was determined using ICD-9-CM and CPT codes. Patient demographics and comorbidities were recorded and treatment strategy was stratified by erectile dysfunction status.
RESULTS: A total of 1,655 men underwent surgery for Peyronie 0 s Disease, corresponding to a rate of 1.9 cases per 100,000 person-years. Of the 1,655 men treated surgically for PD, 69.7% had concomitant ED. 97% (1124/1154) of these men underwent inflatable penile prosthesis (IPP) placement. Amongst men with PD who underwent IPP, 56.7% (637/1124) were treated with a concomitant straightening procedure. The use of plaque excision or incision and grafting Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e583
